Infectious Respiratory Disease Diagnostics Market Size Is Anticipated To Reach USD 43.6 Billion By 2030
![Image](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgBsGVnZtv3LjJ_K7O5fNaqUvfznwZ0WWNZEwiuqEgEEP2eWzayFik1-DsSf9VG_NgYrNp1oEAl1_rEiElSpjQEHLcMCE4pU7pH0CSEnEZQc8aMJawHmZp5TI-KK46gLJg9_WfcV-O7KzmorIrgh9OtOhMDZHVDqzvK2Be04erj78iIhYVtS4JnmWxi7oGp/s320/Infectious%20Respiratory%20Disease%20Diagnostics%20Market.png)
San Francisco, 2 Aug 2023: The Report Infectious Respiratory Disease Diagnostics Market Size, Share & Trends Analysis By Product Type (Instruments, Services), By Sample Type (Blood, NPS), By Application, By Technology, And Segment Forecasts, 2022 - 2030 The global infectious respiratory disease diagnostics market size is expected to reach USD 43.6 billion by 2030, registering a CAGR of -1.8% over the forecast period, according to a new report by Grand View Research, Inc. The decline in market size is majorly attributed to the decline in COVID-19 testing. However, the market without the impact of COVID-19 is expected to grow over the forecast years. The growth can be attributed to an increase in the prevalence of infectious respiratory diseases and initiatives taken by governments & nonprofit organizations to introduce novel & innovative products to address the increasing demand. For instance, the global investment in tuberculosis R&D reached USD 915 million, and a